Actively Recruiting
A Pilot Study of a Remote ADHD Monitoring Program
Led by IDeA States Pediatric Clinical Trials Network · Updated on 2026-04-28
36
Participants Needed
2
Research Sites
73 weeks
Total Duration
On this page
Sponsors
I
IDeA States Pediatric Clinical Trials Network
Lead Sponsor
M
Medical University of South Carolina
Collaborating Sponsor
AI-Summary
What this Trial Is About
RAMP is a pilot study examining the use of an Attention-Deficit/Hyperactivity Disorder (ADHD) Monitoring Program during the early stages of treating ADHD in children living in rural settings. This trial will enroll 36 caregiver/infant dyads across 2 sites and will evaluate feasibility endpoints rather than clinical outcomes. Enrolled participants will be randomized 1:1 to the intervention group (RAMP reports) or control group (digital education handouts). The study duration is 10 months, including start-up, enrollment and intervention, and data analysis and manuscript submission.
CONDITIONS
Official Title
A Pilot Study of a Remote ADHD Monitoring Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Child is under the care of a participating provider
- Child is aged 5 to 11 years at enrollment
- Child has a diagnosis of ADHD
- Child is starting stimulant medication for treatment for the first time or has not received stimulant medication in the last 6 months
- Child is attending in-person elementary school
- Primary caregiver is willing and legally able to give consent
- Primary caregiver has access to a smartphone
- Primary caregiver is English-speaking
- Primary caregiver resides with the child at least 3 days per week
- Primary caregiver completes an initial symptom assessment before starting stimulant treatment and agrees to provide a copy to the study team
- Provider manages ADHD care in patients aged 5 to 11 years
- Provider provides informed consent
- Provider agrees to use the RAMP platform if caring for patients randomized to it
- Provider agrees to inform potential participants about the study and contact the research coordinator if interested
You will not qualify if you...
- Child has serious mental health comorbidities such as schizophrenia, bipolar disorder, conduct disorder, or has been hospitalized for any mental health condition
- Child has severe neurodevelopmental disorders (children with well-controlled seizure disorders are allowed)
- Child is currently receiving or has previously received atypical antipsychotic medication treatment
- Child is or becomes pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University of Mississippi Medical Center
Jackson, Mississippi, United States, 39216
Actively Recruiting
2
Medical University of South Carolina
Charleston, South Carolina, United States, 29425
Actively Recruiting
Research Team
S
Song Ounpraseuth, PhD
CONTACT
K
Kripa Patel, BDS, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here